| Structure | Chemical Name | CAS | MF |
|
Carbamic acid,N-(7-bromopyrrolo[2,1-f][1,2,4]triazin-4-yl)-,1,1-dimethylethyl ester
|
2328091-01-4
|
C11H13BrN4O2
|
|
3-Pyridinecarboxamide, 2-amino-5-[3-(1-piperazinyl)phenyl]-N-4-pyridinyl-
|
2328094-11-5
|
C21H22N6O
|
|
Benzaldehyde, 2-hydroxy-4-(1,2,2-triphenylethenyl)-
|
2328097-79-4
|
C27H20O2
|
|
Nonanoic acid, 9,9′,9′′,9′′′,9′′′′,9′′′′′-[1,3,5-benzenetriyltris(carbonylimino-3,1-propanediylnitrilo)]hexakis-, 1,1′,1′′,1′′′,1′′′′,1′′′′′-hexakis(1-propylpentyl) ester
|
2328129-27-5
|
C120H222N6O15
|
|
Tofacitinib Impurity K
|
2328165-36-0
|
C16H21N5O3
|
|
N2-iso-Butyryl-8-azaguanosine
|
2328168-83-6
|
C13H18N6O6
|
|
ethyl trans-1-benzyl-4-(4-methoxyphenyl)pyrrolidine-3-carboxylate
|
2329045-02-3
|
C21H25NO3
|
|
Trans-ethyl-1-benzyl-4-(2，5-difluorophenyl)pyrrolidine-3-carboxylate
|
2329045-05-6
|
C20H21F2NO2
|
|
ethyl trans-1-benzyl-4-(3，4-dimethoxyphenyl)pyrrolidine-3-carboxylate
|
2329045-07-8
|
C22H27NO4
|
|
4,7-bis(7-bromo-2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-5,6-dinitrobenzo[c][1,2,5]thiadiazole
|
2329343-61-3
|
C18H8Br2N4O8S3
|
|
4,4',4''-(1H-imidazole-2,4,5-triyl)tribenzoic acid
|
2329408-06-0
|
C24H16N2O6
|
|
9H-Carbazole, 9-[5'-(4,6-diphenyl-1,3,5-triazin-2-yl)[1,1':3',1''-terphenyl]-2'-yl]-3,6-diphenyl-
|
2329651-89-8
|
C57H38N4
|
|
Moxifloxacin Impurity 80
|
2331091-31-5
|
C21H23ClFN3O4
|
|
(1S,5S,7S)-2-Boc-7-amino-2-azabicyclo[3.2.0]heptane
|
2331211-37-9
|
C11H20N2O2
|
|
(1R, 4R)-2,5-Diaza-bicyclo[2.2.1]heptane dihydrochloride
|
2331211-51-7
|
C5H11ClN2
|
|
Cyclohexanol, 3-amino-, hydrochloride (1:1), (1S,3R)-
|
2331211-57-3
|
C6H14ClNO
|
|
(1R,3S)-3-Methoxy-cyclohexylamine hydrochloride
|
2331211-70-0
|
C7H16ClNO
|
|
4H-1,4-Benzoxazine-4-carboxylic acid, 2,3-dihydro-, 7-[(4-chlorophenyl)methyl]hexahydro-1,3-dioxoimidazo[1,5-a]pyrazin-2-yl ester
|
2331255-53-7
|
C22H21ClN4O5
|
|
Pomalidomide-PEG4-NH2 hydrochloride
|
2331259-45-9
|
|
|
3-Fluoromethyl-piperazine-1-carboxylic acid tert-butyl ester hydrochloride
|
2331259-80-2
|
C10H20ClFN2O2
|
|
4-(2H-Pyrazol-3-yl)-benzylamine dihydrochloride
|
2331260-15-0
|
C10H12ClN3
|
|
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride
|
2331268-15-4
|
C14H16ClN7
|
|
Itopride Impurity 1
|
2332724-21-5
|
C25H25NO7
|
|
PSB-1901
|
2332835-02-4
|
C24H25BrN6O4S
|
|
Nav1.1 activator 1
|
2332897-85-3
|
C24H23F3N4O
|
|
4-bromo-7-fluoro-2,3-dihydro-1H-indene
|
2332943-95-8
|
C9H8BrF
|
|
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A
|
2332972-26-4
|
C24H22FNO4S
|
|
Benzeneethanamine, 2,4-dichloro-β-[(4-chlorophenyl)methoxy]-
|
2334059-11-7
|
C15H14Cl3NO
|
|
[1,1':3',1''-Terphenyl]-4,4''-diamine, 5'-bromo-
|
2337335-29-0
|
C18H15BrN2
|
|
CAY10749
|
2337386-47-5
|
C33H28F4N8O3
|
|
2-[2-[(tert-Butyldimethylsilyl)oxy]phenyl]acetonitrile
|
2338684-84-5
|
C14H21NOSi
|
|
AHR antagonist 2
|
2338747-54-7
|
C20H17F3N4O3
|
|
Phenol, 3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-
|
2338840-88-1
|
C18H15FOS
|
|
Parecoxib Sodium EJF
|
2338845-31-9
|
C32H24N2O4S
|
|
tris(3'-carboxybiphenyl)amine
|
2338875-40-2
|
C39H27NO6
|
|
(6bR,10aS)-2,3,6b,7,8,9,10,10a-Octahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline dihydrochloride
|
2339905-28-9
|
C14H20ClN3
|
|
Palbociclib-006
|
2340184-77-0
|
C14H14N6O4
|
|
4-(3-Thienyl)-3-(trifluoromethyl)benzoic Acid
|
2340293-28-7
|
C12H7F3O2S
|
|
BI 3663
|
2341740-84-7
|
C44H42F3N7O12
|
|
VH 032-linker 7
|
2341796-73-2
|
C25H36ClN5O4S
|
|
VH032-C10-NH2
|
2341796-74-3
|
C33H51N5O4S
|
|
(S,R,S)-AHPC-C10-NH2 dihydrochloride
|
2341796-75-4
|
C33H52ClN5O4S
|
|
VH 032-linker 12
|
2341796-76-5
|
C28H42ClN5O6S
|
|
VH 032-linker 8
|
2341796-77-6
|
C29H44ClN5O4S
|
|
VH032-C4-NH2 dihydrochloride
|
2341796-78-7
|
C27H40ClN5O4S
|
|
L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
2341796-79-8
|
C31H47N5O4S
|
|
BMS-470539 dihydrochloride
|
2341796-82-3
|
C32H42ClN5O4
|
|
dBRD9
|
2341840-98-8
|
C40H46ClN7O10
|
|
Thalidomide-linker 6
|
2341840-99-9
|
C15H16ClN3O5
|
|
-ether-PEG5-amine
|
2341841-01-6
|
C25H36ClN3O10
|
|
Thalidomide-linker 10
|
2341841-02-7
|
C17H19ClN4O6
|
|
JMS 17-2 hydrochloride
|
2341841-07-2
|
C25H27Cl2N3O
|
|
8H-Indeno[1,2-d]oxazole, 2,2'-cyclohexylidenebis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-
|
2341858-19-1
|
C27H28N2O2
|
|
9H-Purine-2,6-diamine, 9-(1-cyclopropylethyl)-N2-[2-(dimethylamino)ethyl]-N6-[[3-(trifluoromethyl)phenyl]methyl]-
|
2342583-66-6
|
C22H28F3N7
|
|
Telmisartan n-Butyl Ester
|
2342587-28-2
|
C37H38N4O2
|
|
Garivulimab
|
2342597-81-1
|
|
|
|
Surzebiclimab
|
2342597-90-2
|
|
|
|
Ociperlimab
|
2342597-93-5
|
|
|
5-((4-Bromo-1H-pyrazol-1-yl)methyl)-2-fluoropyridine
|
2342610-58-4
|
C9H7BrFN3
|
|
(1R)-1-(4-BROMOTHIOPHEN-2-YL)ETHAN-1-AMINE HCl
|
2343963-75-5
|
C6H9BrClNS
|
|
3-bromo-2-(chloromethyl)-6-methylpyridine
|
2344679-29-2
|
C7H7BrClN
|
|
5-benzyl-5-azaspiro[3.5]nonan-8-one
|
2344680-14-2
|
C15H19NO
|
|
1H-Benz[f]indene-1,3(2H)-dione, 6,7-difluoro-
|
2344682-62-6
|
C13H6F2O2
|
|
7-Azaspiro[3.5]nonan-6-one
|
2344685-49-8
|
C8H13NO
|
|
(S)-4,4-difluoropyrrolidin-3-ol hydrochloride
|
2344751-63-7
|
C4H8ClF2NO
|
|
2-Thiophenecarboxaldehyde, 4-(2-ethylhexyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
2344786-93-0
|
C19H31BO3S
|
|
4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole hydrochloride
|
2345598-03-8
|
C10H18BClN2O2
|
|
|
5',5""-oxybis(2'-amino-[1,1':3',1"-terphenyl]-4,4"-dicarboxylic acid)
|
2345749-57-5
|
C40H28N2O9
|
|
(1-Benzylindol-5-yl)boronic acid
|
2346512-57-8
|
C15H14BNO2
|
|
[1,?1'-?Biphenyl]?-?4-?carboxaldehyde, 4'-?[3,?5,?6-?tris(4'-?formyl[1,?1'-?biphenyl]?-?4-?yl)?-?2-?pyrazinyl]?-
|
2346577-92-0
|
C56H36N2O4
|
|
m-PEG17-acid
|
2346581-96-0
|
C36H72O19
|
|
((3aR,4R,6R,6aR)-6-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
|
2346620-53-7
|
C16H22N2O7
|
|
((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
|
2346620-54-8
|
C18H23N5O6
|
|
((3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
|
2346620-55-9
|
C16H23N3O7
|
|
7H-Pyrrolo[2,3-d]pyrimidine, 2,5-dichloro-
|
2347374-92-7
|
C6H3Cl2N3
|
|
Netupitant Impurity
|
2347562-52-9
|
C18H21N3O2
|
|
4-[2-[(2-Bromo-4-pyridyl)oxy]ethyl]morpholine
|
2347600-07-9
|
C11H15BrN2O2
|
|
N-Fmoc-O-(2-methoxyphenyl)-L-serine
|
2348285-89-0
|
C25H23NO6
|
|
N-Boc-O-ethyl-D-homoserine
|
2348286-55-3
|
C11H21NO5
|
|
Cyclopropaneacetic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-methyl-, (αS)-
|
2348287-11-4
|
C21H21NO4
|
|
1-Cyclohexene-1-propanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αS)-
|
2348299-84-1
|
C24H25NO4
|
|
(2S)-4-(4-cyanophenyl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoic acid
|
2348310-52-9
|
C26H22N2O4
|
|
2H-Pyran-4-butanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]tetrahydro-, (αS)-
|
2348350-11-6
|
C24H27NO5
|
|
Benzenehexanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-fluoro-, (αS)-
|
2348351-05-1
|
C27H26FNO4
|
|
Fmoc-(2R)-2-amino-5-(4-fluorophenyl)pentanoic acid
|
2348351-11-9
|
C26H24FNO4
|
|
Adenosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-N-methyl-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
|
2348385-04-4
|
C42H52N7O7P
|
|
Aprepitant EP Impurity B
|
2348441-62-1
|
C29H25F7N4O3
|
|
Aprepitant EP Impurity C
|
2348441-63-2
|
C29H25F7N4O3
|
|
6-(2-methoxyethoxy)-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate
|
2348470-19-7
|
C16H12F3NO7S
|
|
2-Bromo-5,11-di-tert-butyl-indolo[3,2,1-jk]carbazole
|
2348500-70-7
|
C26H26BrN
|
|
1H-Pyrazolo[4,3-c]pyridine, 3-bromo-6-chloro-1-[[2-(trimethylsilyl)ethoxy]methyl]-
|
2348512-74-1
|
C12H17BrClN3OSi
|
|
Afatinib Impurity 75
|
2348580-72-1
|
C7H14N2O
|
|
Fmoc-2-amino-5-phenyl(2,3-Difluoro)-L-pentanoic acid
|
2349313-65-9
|
C26H23F2NO4
|
|
Benzenebutanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-iodo-, (αS)-
|
2349317-02-6
|
C25H22INO4
|
|
Benzenepentanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-hydroxy-, (αS)-
|
2349331-35-5
|
C26H25NO5
|
|
Fmoc-2-amino-5-phenyl(2,5-Dimethyl)-L-pentanoic acid
|
2349332-10-9
|
C28H29NO4
|
|
N-[2-[[5-Chloro-2-[[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]amino]phenyl]-N-methylmethanesulfonamide
|
2349336-18-9
|
C29H39ClN8O3S
|
|
L-Tyrosine, 2-chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-methyl-
|
2349340-78-7
|
C25H22ClNO5
|
|
Pentanoic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-5,5,5-trifluoro-, (3S)-
|
2349340-84-5
|
C20H18F3NO4
|
|
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[(1S,2R)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-
|
2349341-85-9
|
C18H34N4O9
|